CMS Final Rule Review: CY 2025 ESRD PPS, AKI, QIP, and ESRD Treatment Choices Model

Recorded On: 11/14/2024

This webinar, held on November 14, reviewed the CY 2025 ESRD PPS final rule. Presenters from ATI Advisory and Mehlman Consulting covered key policy changes, answered questions about CMS updates, and discussed the potential impact on RHA members in 2025.


Presented November 2024

Madeleine Howard

Senior Analyst

ATI Advisory

Madeleine joined ATI with a unique background in health policy and business strategy. Prior to joining ATI, Madeleine served as a Health Policy Fellow in the office of Maryland House Delegate Brooke Lierman. In this role, Madeleine conducted in-depth health policy research, drafted policy briefs and op-eds, and contributed to the formulation of state and local public health legislation. As an Analytics Consultant at Axia Women’s Health, Madeleine performed quantitative and qualitative research analyses on health indicators and clinical outcomes within Axia’s patient population and used predictive modeling to help inform Axia’s business growth strategy. Madeleine also previously served as the Midwest Outreach Director for the US Global Leadership Coalition (USGLC), where she worked with federal and state lawmakers to strengthen and advance US foreign policy. Prior to the USGLC, Madeleine worked at the Bill and Melinda Gates Foundation where she served as a Program Assistant on the Global Policy and Advocacy team.

Key:

Complete
Failed
Available
Locked
CMS Final Rule Review: CY 2025 ESRD PPS, AKI, QIP, and ESRD Treatment Choices Model
Recorded 11/14/2024  |  60 minutes
Recorded 11/14/2024  |  60 minutes On November 14, from 11:30am – 12:30pm ET, join ATI Advisory and Mehlman Consulting for a webinar to review the CY 2025 ESRD PPS final rule. Presenters will walk through key policy changes outlined in this regulation, answer questions about CMS’s finalized updates, and discuss how this final rule may impact RHA members in 2025.